Henan Lingrui Pharmaceutical Co Ltd banner

Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 21.52 CNY -0.05% Market Closed
Market Cap: ¥12.2B

Wall Street
Price Targets

Price Targets Summary
Henan Lingrui Pharmaceutical Co Ltd

Wall Street analysts forecast Henan Lingrui Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Henan Lingrui Pharmaceutical Co Ltd is 29.12 CNY with a low forecast of 27.37 CNY and a high forecast of 31.5 CNY.

Lowest
Price Target
27.37 CNY
27% Upside
Average
Price Target
29.12 CNY
35% Upside
Highest
Price Target
31.5 CNY
46% Upside
Henan Lingrui Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 3 years is 13%.

Operating Income
Forecast

28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's operating income is 28%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's net income is 28%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Henan Lingrui Pharmaceutical Co Ltd's stock price target?
Price Target
29.12 CNY

According to Wall Street analysts, the average 1-year price target for Henan Lingrui Pharmaceutical Co Ltd is 29.12 CNY with a low forecast of 27.37 CNY and a high forecast of 31.5 CNY.

What is Henan Lingrui Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 3 years is 13%.

What is Henan Lingrui Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's operating income is 28%. The projected CAGR for the next 3 years is 12%.

What is Henan Lingrui Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Henan Lingrui Pharmaceutical Co Ltd's net income is 28%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett